Rare diseases
Investigational molecules
Locations
Recruiting trials first
1 clinical trial in this condition
SwedenIn short
Facial paresis, also known as facial paralysis, occurs when weakness or complete loss of movement affects the muscles on one or both sides of the face due to damage to the facial nerve. Treatment approaches vary widely depending on the underlying cause, the severity of symptoms, and how long the condition has lasted. While some people recover naturally within weeks or months, others may benefit from medications, physical therapy, or advanced surgical procedures aimed at restoring facial movement, protecting the eye, and improving quality of life.
When facial paresis strikes, the immediate priority is to determine its cause and begin appropriate treatment as quickly as possible. The main goals of treating facial paresis include restoring facial muscle function, preventing complications such as eye damage, improving symmetry of the face, and helping patients regain their ability to perform everyday activities like eating, speaking, and expressing emotions. Treatment decisions depend heavily on what caused the paralysis in the first place, how severe the weakness is, and whether the condition is temporary or permanent.
Facial nerve damage can happen for many reasons, including infections, inflammation, trauma from accidents or surgery, strokes, or tumors. Sometimes the cause remains unknown, which is referred to as Bell's palsy, a condition where sudden weakness appears on one side of the face without any clear trigger. In about 70% of cases, Bell's palsy is the reason behind facial nerve problems.
Treatment is not one-size-fits-all. For example, if facial paresis results from a stroke, doctors focus on stroke treatment. If a tumor is pressing on the facial nerve, removing that tumor becomes the priority. When Bell's palsy is diagnosed, medications and exercises may be recommended to support recovery. The timing of treatment is also crucial—starting therapy within the first few days of symptom onset can make a significant difference in outcomes.
Standard treatment for facial paresis varies based on the underlying cause, but several well-established methods are commonly used. These treatments aim to reduce inflammation, protect vulnerable structures like the eye, support muscle function, and promote nerve recovery.
When Bell's palsy is diagnosed, corticosteroids are often the first line of treatment. Corticosteroids such as prednisone work by reducing inflammation and swelling in the facial nerve, which can help improve the chances of recovery. Medical guidelines, including those from the American Academy of Neurology, recommend starting corticosteroids within the first few days of symptom onset for the best results. Studies show that corticosteroids are highly likely to increase the likelihood of recovering facial nerve function in new-onset Bell's palsy.
Antiviral medications such as acyclovir have also been used alongside corticosteroids, particularly when a viral infection is suspected as the trigger for facial nerve damage. However, recent evidence suggests that antivirals may not provide additional benefit beyond what corticosteroids alone can achieve.
Recovery from Bell's palsy can take time. Most people begin to see improvement within a few weeks, and complete recovery occurs in about six months for many patients. However, recovery is incomplete in as many as 13% of patients, and up to 10% may experience recurrence.
One of the most critical aspects of facial paresis treatment is protecting the eye on the affected side. When the facial nerve is damaged, the ability to blink and fully close the eyelid is often lost. This leaves the cornea, the clear front surface of the eye, exposed to drying, irritation, and potential injury. Without proper care, serious complications such as corneal ulcers or vision loss can occur.
Patients are typically advised to use preservative-free artificial tears (lubricating eye drops) throughout the day to keep the eye moist. At night, a thicker eye ointment is applied to provide longer-lasting protection while sleeping. Many patients are also instructed to tape the eyelid closed at bedtime using medical tape to prevent the eye from drying out. Wearing protective glasses or goggles outdoors can shield the eye from wind, dust, and debris.
Physical therapy plays a valuable role in facial paresis recovery. Facial strengthening exercises and neuromuscular retraining techniques help improve facial symmetry, increase muscle strength, and restore coordination of facial movements. A physical therapist trained in facial nerve disorders can guide patients through specific exercises tailored to their needs. These exercises are designed to encourage proper nerve regeneration and prevent unwanted muscle movements.
Gentle facial massage using light fingertip pressure in small circles across the cheek, around the eye, and along the jawline can help ease muscle tension. Applying a warm, damp washcloth to the face for 10 to 15 minutes several times a day may also support muscle relaxation. It is important to perform exercises correctly, as improper techniques can interfere with nerve healing.
Speech therapy may be recommended for patients who have trouble speaking or swallowing due to facial muscle weakness. Occupational therapy can help patients improve their ability to perform daily tasks and enhance interpersonal communication by working on facial expressions.
In some cases, patients with facial paresis develop a condition called synkinesis, where involuntary muscle movements occur during intended facial expressions. For example, the eye might close when the person tries to smile. Botox (botulinum toxin) injections can be used to treat synkinesis by relaxing overactive muscles and reducing these unwanted movements. Botox is commonly used in Bell's palsy patients who experience this complication.
When facial paresis is severe, long-lasting, or does not respond to conservative treatments, surgery may be considered. There are several surgical options depending on the specific problem and the patient's goals.
Eyelid surgery is performed to help the eye close more efficiently and protect the cornea. Various procedures can support the eyelid and improve blinking. For example, gold eyelid weights or platinum chains can be implanted in the upper eyelid to help gravity close the eye. Eyelid springs are another option that use a mechanical mechanism to assist closure.
Facial reanimation surgery encompasses a group of procedures aimed at restoring movement to the paralyzed side of the face. The type of surgery chosen depends on factors such as how long the paralysis has been present and which facial muscles are affected. Reanimation procedures may involve nerve transfers, where a nearby functioning nerve is connected to the facial nerve to provide new input. Tendon transfers or muscle transplants, such as the gracilis free flap, involve taking muscle tissue from another part of the body and transplanting it into the face to restore movement. One common nerve transfer technique is the nerve to masseter transfer, which uses the nerve that controls the chewing muscle to power facial movements.
If facial paresis is caused by a tumor, surgery to remove the tumor may be necessary. In cases where the facial nerve is compressed within the bone, facial nerve decompression surgery may be performed to relieve pressure and improve function.
While standard treatments have been established for many years, ongoing research continues to explore new and innovative approaches to treating facial paresis. Clinical trials are essential for testing promising therapies and advancing our understanding of how best to restore facial nerve function.
Clinical trials typically progress through different phases. Phase I trials focus on testing the safety of a new treatment in a small group of people. Phase II trials evaluate whether the treatment is effective and continue to monitor safety in a larger group. Phase III trials compare the new treatment to current standard treatments to determine if it offers better results. Phase IV trials occur after a treatment has been approved and are used to monitor long-term effects and gather additional information.
Currently, much of the research in facial paralysis is focused on refining surgical techniques and improving outcomes from existing procedures. For example, studies are exploring the best timing for nerve transfer surgeries and which nerve donor sites produce the most natural facial movements. Researchers are also investigating ways to improve nerve regeneration after injury, including the use of growth factors and other biological agents that might encourage faster and more complete healing.
Advanced imaging techniques are being studied to better assess nerve damage and predict recovery. Electromyography (EMG) and electroneurography are tests that measure electrical activity in muscles and nerves. These tests can help doctors determine the severity of nerve damage and guide treatment decisions. Researchers are working to refine these diagnostic tools to provide more accurate prognoses for patients with facial paresis.
Physical therapy approaches are also evolving. Studies are examining whether certain types of facial exercises or biofeedback techniques can speed recovery and reduce the likelihood of complications such as synkinesis. Biofeedback therapy uses sensors to provide real-time feedback about muscle activity, helping patients learn to control their facial muscles more effectively.
While there are no widely publicized clinical trials testing entirely new drug molecules specifically for facial paresis at this time, research continues in related areas such as neuroprotection and nerve regeneration. Scientists are exploring whether medications that protect nerve cells from damage or enhance their ability to regrow could be beneficial for patients with facial nerve injuries. These investigations are mostly in early stages and have not yet reached large-scale clinical trials.
For patients interested in participating in clinical trials, specialized facial nerve centers at major medical institutions often conduct research studies. Eligibility for trials depends on factors such as the cause of facial paresis, the duration of symptoms, and the patient's overall health. Patients can discuss with their healthcare providers whether any clinical trials might be appropriate for their situation.
This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
